The FDA has cleared the first human trial of an age-rejuvenating gene therapy, ER-100, to test safety and vision outcomes using controlled epigenetic reprogramming. | Interesting Engineering

David Sinclair explains how induced pluripotent stem cells can turn a simple skin cell into a mini-organ, a gamete, or personalized tissue. That’s incredible science — but it also raises serious questions. If we can reprogram cells this easily, who decides how that technology gets used? Medicine, healing, and organ repair are one path… but critics worry about genetic targeting, weaponization, and global health programs gaining unprecedented access to biological data. iPSCs are the future of pers

Success is a mindset and failure is a decision. Change your mind...